Walgreens has been facing financial pressure due to a changing retail environment and increased regulatory and reimbursement challenges on the pharmacy end, according to its Q3 earnings report from ...

Drugstore chain Walgreens reported third-quarter sales were up nearly 9% to reach $35.4 billion, but the company slashed its profit outlook for the year as it faces lower consumer spending and a dr ...

Walgreens reported a 7% jump in sales to reach $39 billion in its fiscal third quarter, reflecting sales growth in its U.S. retail pharmacy and international segments as well as improvements in ...

Walgreens Boots Alliance (NASDAQ: WBA) Q3 2024 Earnings Call Jun 27, 2024, 8:30 a.m. ET. Contents: ... These measures are reconciled to the most directly comparable GAAP financial measures, ...

Walgreens Boots Alliance (WBA) reported $38.99 billion in revenue for the quarter ended May 2025, representing a year-over-year increase of 7.3%. EPS of $0.38 for the same period compares to $0.63 ...

The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 34 cents per share. The largest U.S. drugstore chain ...

The drugstore industry is facing competition from the likes of Amazon.com Inc., as well as pressure on pharmacy-reimbursement ...

Walgreens posts Q3 2023 revenue growth, misses EPS estimates. Open in App ...

Walgreens' Q3 FY ‘22 earnings announcement was a disaster for WBA stock, sending shares below $37, on top of an already lousy year. Read more here.

DEERFIELD, Ill. (AP) — DEERFIELD, Ill. (AP) — Walgreens Boots Alliance Inc. (WBA) on Thursday reported a loss of $175 million in its fiscal third quarter.